Piotr Najgebauer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Piotr Najgebauer has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Monika Staś
Faculty of Chemistry and Pharmacy, University of Opole, Opole, Poland
4 shared publications - Teobald Kupka
Faculty of Chemistry and Pharmacy, University of Opole, 48, Oleska Street, 45-052 Opole, Poland
2 shared publications - Dawid Siodłak
Faculty of Chemistry and Pharmacy, University of Opole, Opole, Poland
1 shared publication - Maciej Miliński
Institute of Chemistry, University of Opole, Oleska St. 48, Opole-45052, Poland
1 shared publication - Radosław Balwierz
Institute of Chemistry, University of Opole, Oleska 48, 45-052 Opole, Poland
1 shared publication - Urszula Skotnicka-Graca
Faculty of Health Protection, Silesian College of Medicine in Katowice, Katowice, Poland
1 shared publication
Latest Publications
- Open Access
- 7 January 2026
- Published by Springer Nature in Structural Chemistry
- Vol. 37 (5) , 1-15
Interaction of ibotenic acid with selected small nanographene oxide (GO) models
- 7 January 2026
- Published by Springer Nature in Structural Chemistry
- Vol. 37 (5) , 1-15
Open AccessInteraction of ibotenic acid with selected small nanographene oxide (GO) models
- 2 May 2024
- Published by Polish Chemical Society in Wiadomości Chemiczne
- Vol. 78 (5) , 507-526
PRZEGLĄD TOKSYN WYSTĘPUJĄCYCH W GRZYBACH
Mushroom toxins are diversified range of toxic chemical compounds. They vary significantly not only in structures but also in toxicity and level of risk they pose. Some, such as amatoxins, are lethal, while others, like psilocybin are intentionally used as hallucinogens. Certain toxins, such as coprine, may be harmful only under specific conditions. Despite centuries of awareness regarding the potential toxicity of mushrooms, intoxications resulting from mushroom consumption still occur. In this review, our aim is to provide an overview of the mushroom toxins. The first part of this work presents the overview of mushroom toxins, detailing their basic features such as structures and toxicity, along with mushroom species in which they occur. In the second part of this article, we describe selected toxins grouped by their toxicity, into five categories: neurotoxins, hepatotoxins, cytotoxins, nephrotoxins and myostatins.
- 2 May 2024
- Published by Polish Chemical Society in Wiadomości Chemiczne
- Vol. 78 (5) , 507-526
PRZEGLĄD TOKSYN WYSTĘPUJĄCYCH W GRZYBACH
Mushroom toxins are diversified range of toxic chemical compounds. They vary significantly not only in structures but also in toxicity and level of risk they pose. Some, such as amatoxins, are lethal, while others, like psilocybin are intentionally used as hallucinogens. Certain toxins, such as coprine, may be harmful only under specific conditions. Despite centuries of awareness regarding the potential toxicity of mushrooms, intoxications resulting from mushroom consumption still occur. In this review, our aim is to provide an overview of the mushroom toxins. The first part of this work presents the overview of mushroom toxins, detailing their basic features such as structures and toxicity, along with mushroom species in which they occur. In the second part of this article, we describe selected toxins grouped by their toxicity, into five categories: neurotoxins, hepatotoxins, cytotoxins, nephrotoxins and myostatins.
- Open Access
- 2 November 2022
- Published by Springer Nature in Amino Acids
- Vol. 55 (1) , 33-49
Imidazole-amino acids. Conformational switch under tautomer and pH change
Replacement of the main chain peptide bond by imidazole ring seems to be a promising tool for the peptide-based drug design, due to the specific prototropic tautomeric as well as amphoteric properties. In this study, we present that both tautomer and pH change can cause a conformational switch of the studied residues of alanine (1–4) and dehydroalanine (5–8) with the C-terminal peptide group replaced by imidazole. The DFT methods are applied and an environment of increasing polarity is simulated. The conformational maps (Ramachandram diagrams) are presented and the stability of possible conformations is discussed. The neutral forms, tautomers τ (1) and π (2), adapt the conformations αRτ (φ, ψ = − 75°, − 114°) and C7eq (φ, ψ = − 75°, 66°), respectively. Their torsion angles ψ differ by about 180°, which results in a considerable impact on the peptide chain conformation. The cation form (3) adapts both these conformations, whereas the anion analogue (4) prefers the conformations C5 (φ, ψ = − 165°, − 178°) and β2 (φ, ψ ~ − 165°, − 3°). Dehydroamino acid analogues, the tautomers τ (5) and π (6) as well as the anion form (8), have a strong tendency toward the conformations β2 (φ, ψ = − 179°, 0°) and C5 (φ, ψ = − 180°, 180°). The preferences of the protonated imidazolium form (7) depend on the environment. The imidazole ring, acting as a donor or acceptor of the hydrogen bonds created within the studied residues, has a profound effect on the type of conformation.
- 2 November 2022
- Published by Springer Nature in Amino Acids
- Vol. 55 (1) , 33-49
Open AccessImidazole-amino acids. Conformational switch under tautomer and pH change
Replacement of the main chain peptide bond by imidazole ring seems to be a promising tool for the peptide-based drug design, due to the specific prototropic tautomeric as well as amphoteric properties. In this study, we present that both tautomer and pH change can cause a conformational switch of the studied residues of alanine (1–4) and dehydroalanine (5–8) with the C-terminal peptide group replaced by imidazole. The DFT methods are applied and an environment of increasing polarity is simulated. The conformational maps (Ramachandram diagrams) are presented and the stability of possible conformations is discussed. The neutral forms, tautomers τ (1) and π (2), adapt the conformations αRτ (φ, ψ = − 75°, − 114°) and C7eq (φ, ψ = − 75°, 66°), respectively. Their torsion angles ψ differ by about 180°, which results in a considerable impact on the peptide chain conformation. The cation form (3) adapts both these conformations, whereas the anion analogue (4) prefers the conformations C5 (φ, ψ = − 165°, − 178°) and β2 (φ, ψ ~ − 165°, − 3°). Dehydroamino acid analogues, the tautomers τ (5) and π (6) as well as the anion form (8), have a strong tendency toward the conformations β2 (φ, ψ = − 179°, 0°) and C5 (φ, ψ = − 180°, 180°). The preferences of the protonated imidazolium form (7) depend on the environment. The imidazole ring, acting as a donor or acceptor of the hydrogen bonds created within the studied residues, has a profound effect on the type of conformation.
- Open Access
- 29 August 2022
- Published by Polish Pharmaceutical Society in Farmacja Polska
- Vol. 78 (6) , 326-335
Are peptide drugs the future of medicine?
- 29 August 2022
- Published by Polish Pharmaceutical Society in Farmacja Polska
- Vol. 78 (6) , 326-335
Open AccessAre peptide drugs the future of medicine?